...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
2
Nov 21, 2019 12:54PM

Do you have a link for the extention of the trial of Phase 2a mCRPC trial,

What phase is this new extention phase 3??   Nov  2022, I thought these cancer trials were short.....   this has been 4 or  5 years and now an extention to 2020,  What about a breakthough status on this trial,   It seems to be working so far as all these patients are survivors and the trial is not blinded , What gives?

6
Nov 21, 2019 01:21PM
5
Nov 21, 2019 01:48PM
6
Nov 21, 2019 01:49PM
7
Nov 21, 2019 02:15PM
6
Nov 21, 2019 02:30PM
7
Nov 21, 2019 02:47PM
Share
New Message
Please login to post a reply